Health

The ENVIE study conducted in France shed light on the potential of the monoclonal antibody nirsevimab in protecting young infants against hospitalization for respiratory syncytial virus (RSV). The study reported significant effectiveness of nirsevimab in preventing RSV-related bronchiolitis, pediatric intensive care unit (PICU) admissions, and mechanical ventilation in infants younger than 12 months of age.
0 Comments
An intriguing study presented at the recent American Society of Clinical Oncology (ASCO) meeting highlighted the potential of using liposomal gemcitabine in combination with pembrolizumab for the treatment of advanced solid tumors. This groundbreaking research opens up new possibilities for patients with challenging malignancies. The utilization of liposomal gemcitabine represents a significant advancement in oncology.
0 Comments
House Republicans have initiated an investigation and requested a closed-door interview with President Biden’s physician, Dr. Kevin O’Connor, following concerns about Biden’s recent debate performance. This move raises questions about the motives behind the probe and the potential implications for the physician’s reputation and credibility in the medical community. An intense heat wave has shattered
0 Comments
Healthcare professionals are constantly evaluating the effectiveness of different strategies to provide the best possible care for their patients. According to Sara Karaba, MD, PhD, MHS, from Johns Hopkins University School of Medicine, utilizing extended infusion antibiotics for bloodstream infections is a tactic that delivers “the most bang for its buck.” This highlights the importance
0 Comments
Recently, a Seattle-area plastic surgery provider, Allure Esthetic, and its owner, Javad Sajan, were accused of engaging in unethical practices such as posting fake positive reviews and threatening patients over negative ones. This led to a lawsuit being brought against them by Attorney General Bob Ferguson, resulting in a federal consent decree that requires Allure
0 Comments
Medical professionals across the country are expressing frustration with the long waiting times for insurers to respond to prior authorization requests. Dr. Sabin Dang from the Retina Institute in Missouri has bluntly stated that these delays are a waste of everybody’s time. This issue is causing delays in patient care and treatment plans, leading to
0 Comments